The Invisible Latino HIV Crisis
In May 2024, the Centers for Disease Control and Prevention (CDC) released its annual HIV surveillance reports. The new data show a continuation of year-over-year reductions through 2022 in the estima...
10 Huhti 202521min
Updates in Syphilis: Looking Back to Look Forward
Let’s dive in! This month, we welcome new hosts Patrick Passarelli, MD, an infectious diseases fellow at the University of Rochester, and Nicholas Gerbino, a public health professional at the Monroe C...
13 Maalis 202534min
The Role of Opioid Treatment Programs in Hepatitis C Care: A Path to Elimination
Between 2010 and 2022 (the latest year for which data are available), 194,375 New Yorkers were diagnosed with hepatitis C (HCV) and of those, 53% (103,213 individuals) are known to have cleared their ...
13 Helmi 202520min
Use of Injectable Cabotegravir for HIV PrEP in Pregnancy
This podcast outlines some of the data presented at the 25th International AIDS Conference from HPTN 084 as it pertains to using injectable cabotegravir for HIV PrEP during pregnancy. Related Content:...
9 Tammi 20259min
Compassionate Care for LGBTQ+ Individuals Struggling with Substance Use Disorder
Research suggests that LGBTQ adults have higher rates of substance use and mental health issues, compared to their heterosexual cisgender peers. These health disparities are often related to minority...
12 Joulu 202428min
Reflections from the 2024 CDC STI Prevention Conference
For the first time since 2018 and since the COVID-19 pandemic, the Centers for Disease Control and Prevention hosted their biennial STI Prevention Conference in-person in Atlanta, GA from September 16...
7 Marras 202422min
The Case for Chronic Pain Management among People Who Use Opioids
Are current guidelines failing chronic pain patients with a history of substance-use disorders? Find out why Dr. Wang and Dr. Kelly are calling for urgent policy changes and how updated guidelines can...
10 Loka 202446min
An Exciting New Twice-yearly Option for HIV PrEP
“This podcast discusses the recent presentation of data for lenacapavir, a potent capsid inhibitor for HIV that was 100% effective in preventing HIV infection in cis-gender woman at risk for HIV. If a...
10 Syys 202413min
